Navigation Links
Botox Treatment Now With A Lesser Dose And Increased Safety

The fight against the unsightly wrinkles and for smooth complexion just could be getting better. Researchers have discovered a new and interesting// way to increase the potency of botulinum neurotoxin treatments also called Botox. They feel that this new method would soon allow patients to receive the injections less frequently while maintaining or even enhancing its cosmetic benefits.

According to scientists at the Scripps Research Institute in La Jolla, California. by allowing lower doses, the new approach could make the treatment safer by reducing the risk of complications associated with immune system recognition that can sometimes occur with frequent injections. Smaller, more potent doses would even lead reduce the prices for the popular wrinkle remover, they feel.

Botox is also used to treat a growing number of other conditions, including migraine headaches, lazy eyes and excessive sweating. It is developed from the botulinum neurotoxin, the most lethal poison known and a potential bio terrorist weapon. In a medical setting, small doses this toxin blocks the release of a chemical acetylcholine that is necessary for muscle contraction, this in turn results in a localized, temporary paralysis that erases wrinkles and unwanted muscle spasms.

Kim Janda, Ph.D, a chemistry professor at Scripps and head of the research study, and his associates says that they have developed a synthetic molecule that binds to the toxin and increases its normal function, The discovery of small molecule activators may ultimately provide a valuable method for minimizing dosage, reducing resistance, and increasing its clinical efficacy he felt.

The new treatment has not yet been tested in humans or animals, the researchers say. If further studies prove successful, the technique could be available to consumers in four to six years, the researchers estimate.

One of the most important complications of Botox injections is that their repeated use can lead to recognition by the immune system, especially when patients are given frequent, high doses of the toxin. Higher doses can also increase the risk of adverse complications, which can include pain in the face, redness at the injection site and muscle weakness.

Their study is published in the March 29 issue of the weekly Journal of the American Chemical Society.
'"/>




Related medicine news :

1. New antiperspirant in action - Botox does the difference
2. New Research Has Found Another Use For Botox
3. Botox for children with neurological impairments
4. Yet Another Use For Botox
5. Botox Found To Be Effective for Voice Tremors
6. Botox Relieves Neuralgic Pain
7. Botox Can Be a Competent Painkiller
8. Treatment Resistant Tumors Can Be Targeted Better Using Botox
9. Enlarged Prostate Might Be Relieved with Botox injections
10. Muslims in Malaysia Banned from Using Botox
11. Botox Minimizes Facial Scarring
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/22/2017)... ... June 22, 2017 , ... Children’s National Health System ... (AHA) to launch a Rheumatic Heart Disease Center, with the goal of developing ... heart disease (RHD) in high-risk, financially disadvantaged countries and low-income communities across the ...
(Date:6/22/2017)... California (PRWEB) , ... June 22, 2017 , ... A ... Nira Rittenberg to a correspondent concerned about an apparent lack of oral hygiene by ... who specializes in geriatrics and dementia-related matters, suggests a number of steps, including scheduling ...
(Date:6/20/2017)... , ... June 20, 2017 , ... ... organization, announces recipients of its annual “UBBIE” Awards (pronounced you-bee) for 2017. ... demonstrated significant achievements toward their involvement with UBA, the clients they serve, and ...
(Date:6/20/2017)... PA (PRWEB) , ... June 20, 2017 , ... Fresenius ... specialize in minimally invasive techniques to treat and manage a wide range of vascular ... strategic rebranding initiative. With more than 65 centers represented by more than 40 local ...
(Date:6/20/2017)... York, NY (PRWEB) , ... June 20, 2017 , ... ... today their continued expansion and success in the clinical trials market. Similar to its ... a track record in the clinical trials marketplace by proving the value of eVisits ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Infusion Group, a brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has ... location. The Iowa facility ... cleanroom—the standard needed to compound intravenous (IV) nutrition formulations. A cleanroom ... "Our new cleanroom will allow us ... Iowa patients," said Phil Rielly , Diplomat ...
(Date:6/1/2017)... 1, 2017 Nutriceutical Holdings (NH), parent company ... (VRS), and KD Pharma Group have decided to join ... KD Pharma Group. KD Pharma Group will become the ... acquire the entire company. "We believe we ... committed to growing the NH companies by providing us ...
(Date:5/26/2017)...  Endo International plc (NASDAQ: ENDP ) announced ... represent the Company in a fireside chat at Goldman Sachs, ... 13, 2017 at 10:40 a.m. PT / 1:40 p.m. ET. ... Rancho Palos Verdes, CA. A ... available on the Company,s website at http://www.endo.com/investors/overview . Participants ...
Breaking Medicine Technology: